Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Three Arch Partners

Investor type Venture Capital
Founders Thomas Fogarty Wilfred Jaeger


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 123
Average round size
The average size of a deal this fund participated in
Portfolio companies 68
Rounds per year 4.24
Lead investments 15
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 38
Key employees 2
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Health Care
  • Biotechnology
  • Medical Device
  • Medical
  • Manufacturing

Three Arch Partners appeared to be the VC, which was created in 1993. The company was established in North America in United States. The leading representative office of defined VC is situated in the Portola Valley.

This organization was formed by Thomas Fogarty, Wilfred Jaeger. We also calculated 2 valuable employees in our database.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Three Arch Partners, startups are often financed by InterWest Partners, Investor Growth Capital Limited, New Leaf Venture Partners. The meaningful sponsors for the fund in investment in the same round are Polaris Partners, Investor Growth Capital Limited, Frazier Healthcare Partners. In the next rounds fund is usually obtained by Accuitive Medical Ventures, Polaris Partners, Investor Growth Capital Limited.

The average startup value when the investment from Three Arch Partners is 10-50 millions dollars. Considering the real fund results, this VC is 2 percentage points less often commits exit comparing to other organizations. Deals in the range of 10 - 50 millions dollars are the general things for fund. The higher amount of exits for fund were in 2014. The fund is constantly included in 2-6 investment rounds annually. The top activity for fund was in 2007. This Three Arch Partners works on 2 percentage points less the average amount of lead investments comparing to the other organizations.

For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has exact preference in some founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. Among the most successful fund investment fields, there are Biotechnology, Health Diagnostics. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline AcuFocus, Cameron Health, Arbor Surgical Technologies

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Three Arch Partners:
Typical Co-investors
Three Arch Partners is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Three Arch Partners:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Accolade Partners District of Columbia, United States, Washington
Acrobator Ventures | Amsterdam, Noord-Holland, The Netherlands
Altamira Management Canada, Ontario, Toronto
Besunyen (Beijing Outsell Health) China, Guangdong, Wanchai
Digital Healthcare Partners -
Financial Times England, London, United Kingdom
Huayi Fangying Beijing, Beijing, China
Invertec Fairford, Gloucestershire, United Kingdom
Lever VC New York, New York, United States
Masters Capital Management Atlanta, Georgia, United States
Miracele China Investment Group China, Futian, Guangdong
Mitani Sangyo Ishikawa Prefecture, Japan, Kanazawa
Octava Foundation -
Royalty Ventures Bengaluru, India, Karnataka
S Capital VC Israel, Tel Aviv, Tel Aviv
Sutton Capital New York, New York, United States
Thrivent Financial Minneapolis, Minnesota, United States
Venturelab England, Leeds, United Kingdom

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation


Health Care
Medical Device
$15M06 Jun 2017 Pennsylvania, United States


Health Care
Medical Device
$34M27 Apr 2015 Pennsylvania, United States

Ocera Therapeutics

$28M06 Nov 2013 Palo Alto, California, United States


Health Care
Health Diagnostics
$48M07 Mar 2013 California, United States

MEI Pharma

$27M05 Nov 2012 San Diego, California, United States

Access Closure

Health Care
Health Diagnostics
Medical Device
$998K01 Oct 2012 Mountain View, California, United States

iScience Interventional

Health Care
Health Diagnostics
$2M27 Jan 2012 California, United States

Access Closure

Health Care
Health Diagnostics
Medical Device
$2M01 Jan 2012 Mountain View, California, United States

Inova Labs

Health Care
Information Technology
Medical Device
Renewable Energy
$17M08 Nov 2011 Austin, Texas, United States


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Three Arch Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: